CMYC protein and mRNA expressions in aggressive type ATLL patients were significantly higher than those of smouldering and chronic types (p < 0.01), and CMYC may accelerate the conversion from indolent to aggressive type ATLL [11]. This evidence concerns the gene MYC and adult T-cell leukemia/lymphoma.